Hot topics in gut Microbiota

United European Gastroenterology Journal

Volumn 1, Issue 5, 2013, Pages 311-318

  Doré, Joël ^a   Simrén, Magnus ^b   Buttle, Lisa ^c   Guarner, Francisco ^d  

^a UMR1319 MICALIS   (France)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c Chill Pill Media LLP   (United Kingdom)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Diet; Gut; Health; Immune system; Microbiota

Indexed keywords

BIODIVERSITY; BRAIN FUNCTION; CARDIOVASCULAR DISEASE; DIET; DIGESTION; GENE SEQUENCE; HEALTH PROMOTION; HOMEOSTASIS; HUMAN; IMMUNITY; IMMUNOREGULATION; INTESTINE FLORA; METABOLIC DISORDER; METABOLISM; OBESITY; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW;

EID: 85006190068     PISSN: 20506406     EISSN: 20506414     Source Type: Journal    
DOI: 10.1177/2050640613502477     Document Type: Review

References (47)

1. Human Microbiome Project C. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486: 207-214.
2. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464: 59-65.
3. Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature 2011; 473: 174-180.
4. Cotillard A, Kennedy SP, Kong LC, et al. Dietary intervention impact on gut microbial gene richness. Nature 2013; Epub ahead of print, 28 August 2013. DOI: 10.1038/nature12480.
5. Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012; 490: 55-60.
6. Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature 2012; 486: 222-227.
7. Sartor RB. Genetics and environmental interactions shape the intestinal microbiome to promote inflammatory bowel disease versus mucosal homeostasis. Gastroenterology 2010; 139: 1816-1819.
8. Hanski I, von Hertzen L, Fyhrquist N, et al. Environmental biodiversity, human microbiota, and allergy are interrelated. P Natl Acad Sci USA 2012; 109: 8334-8339.
9. Rook GA. Hygiene hypothesis and autoimmune diseases. Clin Rev Allerg Immun 2012; 42: 5-15.
10. Blaser MJ and Falkow S. What are the consequences of the disappearing human microbiota? Nature Rev Microbiol 2009; 7: 887-894.
11. Diaz Heijtz R, Wang S, Anuar F, et al. Normal gut microbiota modulates brain development and behavior. P Natl Acad Sci USA 2011; 108: 3047-3052.
12. Bailey MT, Dowd SE, Galley JD, et al. Exposure to a social stressor alters the structure of the intestinal microbiota: Implications for stressor-induced immunomodulation. Brain Behav Immun 2011; 25: 397-407.
13. McDade TW. Early environments and the ecology of inflammation. P Natl Acad Sci USA 2012; 109: S17281-S17288.
14. Rook GAW, Raison CL and Lowry CA. Childhood microbial experience, immunoregulation, inflammation and adult susceptibility to psychosocial stressors and depression in rich and poor countries. Evolution, Medicine and Public Health 2013; 1: 14-17.
15. Mayer EA and Tillisch K. The brain-gut axis in abdominal pain syndromes. Ann Rev Med 2011; 62: 381-396.
16. Rhee SH, Pothoulakis C and Mayer EA. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nature Rev Gastroenterol & Hepatol 2009; 6: 306-314.
17. Walters M and Sperandio V. Autoinducer 3 and epinephrine signaling in the kinetics of locus of enterocyte effacement gene expression in enterohemorrhagic Escherichia coli. Infect Immun 2006; 74: 5445-5455.
18. Cryan JF and O’Mahony SM. The microbiome-gut-brain axis: From bowel to behavior. Neurogastroenterol Motility 2011; 23: 187-192.
19. Cryan JF and Dinan TG. Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour. Nature Rev Neuroscience 2012; 13: 701-712.
20. Bercik P, Denou E, Collins J, et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 2011; 141: 599-609.
21. Bercik P, Park AJ, Sinclair D, et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motility 2011; 23: 1132-1139.
22. Tillisch K, Labus J, Kilpatrick L, et al. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 2013; 144: 1394-1401.
23. Clarke G, Grenham S, Scully P, et al. The microbiomegut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Molecular Psychiatry 2013; 18: 666-673.
24. Prasad HC, Steiner JA, Sutcliffe JS, et al. Enhanced activity of human serotonin transporter variants associated with autism. Philos T Roy Soc B 2009; 364: 163-173.
25. Finegold SM, Dowd SE, Gontcharova V, et al. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 2010; 16: 444-453.
26. Adams JB, Johansen LJ, Powell LD, et al. Gastrointestinal flora and gastrointestinal status in children with autism-comparisons to typical children and correlation with autism severity. BMC Gastroenterol 2011; 11: 22.
27. Cani PD and Delzenne NM. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharma Des 2009; 15: 1546-1558.
28. Delzenne NM, Neyrinck AM, Backhed F, et al. Targeting gut microbiota in obesity: Effects of prebiotics and probiotics. Nature Rev Endocrinol 2011; 7: 639-646.
29. Everard A, Lazarevic V, Derrien M, et al. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 2011; 60: 2775-2786.
30. De Filippo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. P Natl Acad Sci USA 2010; 107: 14691-14696.
31. Lin A, Bik EM, Costello EK, et al. Distinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United States. PloS One 2013; 8: e53838.
32. Wu GD, Chen J, Hoffmann C, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011; 334: 105-108.
33. Albenberg LG, Lewis JD and Wu GD. Food and the gut microbiota in inflammatory bowel diseases: A critical connection. Curr Opin Gastroenterol 2012; 28: 314-320.
34. Van Baarlen P, Troost FJ, van Hemert S, et al. Differential NF-kappa B pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. P Natl Acad Sci USA 2009; 106: 2371-2376.
35. Moayyedi P, Ford AC, Talley NJ, et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: A systematic review. Gut 2010; 59: 325-332.
36. Bravo JA, Forsythe P, Chew MV, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. P Natl Acad Sci USA 2011; 108: 16050-16055.
37. Simren M, Barbara G, Flint HJ, et al. Intestinal microbiota in functional bowel disorders: A Rome foundation report. Gut 2013; 62: 159-176.
38. Kyne L, Warny M, Qamar A, et al. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 2001; 357: 189-193.
39. Chang JY, Antonopoulos DA, Kalra A, et al. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 2008; 197: 435-438.
40. Surawicz CM, Brandt LJ, Binion DG, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 2013; 108: 478-498.
41. Gough E, Shaikh H and Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011; 53: 994-1002.
42. Van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. NEJM 2013; 368: 407-415.
43. Brandt LJ, Aroniadis OC, Mellow M, et al. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol 2012; 107: 1079-1087.
44. Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012; 143: 913-916.
45. Lawley TD, Clare S, Walker AW, et al. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathogens 2012; 8: e1002995.
46. Khoruts A, Dicksved J, Jansson JK, et al. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol 2010; 44: 354-360.
47. Petrof EO, Claud EC, Gloor GB, Allen-Vercoe E. Microbial ecosystems therapeutics: a new paradigm in medicine? Benef Microbes 2013; 4: 53-65.